Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
4
×
drugs
4
×
life sciences
national blog main
boston blog main
boston top stories
national top stories
san diego blog main
san diego top stories
boston
clinical trials
fda
new york blog main
new york top stories
san francisco blog main
san francisco top stories
akcea therapeutics
allergan
alnylam pharmaceuticals
arvinas
barry greene
boston university
boulder/denver blog main
boulder/denver top stories
cancer autoimmune diseases. peloton therapeutics
cedilla therapeutics
crispr
cynthia collins
dan ollendorf
dana-farber cancer institute
detroit blog main
detroit top stories
drug development
editas medicine
entrepreneurship
erythropoietin
gail naughton
gene editing
gregg semenza
hair growth
What
medicine
4
×
cells
clinical
fda
adapt
ago
allergan
alnylam
approve
awaits
biological
blessing
bosley
cellular
ceo
changes
check
cleared
company
cosmeceutical
crispr
crossed
cusp
decades
decision
depart
diego’s
discovered
editas
editing
experimental
female
fingers
friday
gene
gi
goes
hair
histogen
historic
Language
unset
Current search:
drugs
×
medicine
×
biotech
×
@xconomy.com
4 years ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@xconomy.com
5 years ago
Editas CEO Katrine Bosley to Depart on Cusp of CRISPR Clinical Trial
@xconomy.com
5 years ago
Patients Have “Fingers Crossed” As Alnylam Awaits Historic FDA Decision
@xconomy.com
6 years ago
Histogen Treatment for Female Hair Loss Cleared for Clinical Testing
